Physician profile
Ryan Christopher Cleary
NPI 1013232693
$14,637.65
in general payments reported to CMS, 2019-2025
53 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,295 · 2020: $5,266 · 2021: $727 · 2022: $1,781 · 2023: $1,532 · 2024: $1,670 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,534 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,533.70 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,537.97 | 2019-2020 | |
| Janssen Biotech, INC. | $1,255.50 | 2019-2025 | Erleada, Akeega |
| Abbvie INC. | $836.26 | 2022-2025 | Botox |
| Astellas Pharma US INC | $645.05 | 2019-2025 | Xtandi, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $388.19 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $338.10 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $300.76 | 2020-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $259.52 | 2021-2025 | Keytruda, Lynparza |
| Urogen Pharma, INC. | $255.87 | 2022-2025 | |
| Medtronic, INC. | $214.73 | 2022-2023 | Interstim |
| Allergan, INC. | $214.58 | 2019-2022 | |
| Olympus America INC. | $213.62 | 2023-2025 | Itind System |
| Endo Pharmaceuticals INC. | $212.71 | 2019-2023 | Xiaflex, Aveed |
| Immunitybio, INC. | $208.13 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $203.92 | 2021-2024 | Pylarify |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $168.44 | 2019-2023 | Prolia, Xgeva |
| Urovant Sciences INC | $163.55 | 2021-2022 | |
| Baxter Healthcare | $146.18 | 2019 | |
| Novartis Pharmaceuticals Corporation | $143.40 | 2019-2025 | |
| Teleflex LLC | $138.74 | 2022 | |
| Pfizer INC. | $126.75 | 2020-2025 | |
| Neotract INC. | $116.38 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $109.26 | 2019-2022 | |
| Tolmar, INC. | $108.92 | 2024-2025 | Eligard, Jatenzo |
| Dendreon Pharmaceuticals LLC | $103.23 | 2019-2025 | Provenge |
| Astrazeneca Pharmaceuticals LP | $102.20 | 2022-2025 | Lynparza, Imfinzi |
| Ethicon US, LLC | $100.47 | 2023 | Stratafix, Echelon Flex, Surgicel Nu-Knit |
| Myovant Sciences INC. | $92.08 | 2021-2022 | |
| 180 Medical, INC. | $82.50 | 2019-2025 | Gentlecath |
| Tempus Ai, INC | $76.02 | 2025 | Xt Cdx |
| Axonics, INC. | $71.32 | 2020 | |
| Boston Scientific Corporation | $70.40 | 2019-2025 | Ams 800 Artificial Urinary Sphincter |
| Myriad Genetic Laboratories, INC. | $64.31 | 2021-2024 | Prolaris |
| E.R. Squibb & Sons, L.L.C. | $63.98 | 2022 | |
| Renovia INC | $57.73 | 2019 | |
| Endo USA, INC. | $54.98 | 2024-2025 | Aveed, Xiaflex |
| Bioprotect Medical, INC. | $44.84 | 2025 | Bioprotect Balloon Implant System |
| Blue Earth Diagnostics | $43.36 | 2021-2025 | Posluma |
| Ferring Pharmaceuticals INC. | $39.69 | 2024 | Adstiladrin |
| Hollister Incorporated | $34.00 | 2022-2023 | Vapro, Infyna Chic |
| Clarus Therapeutics INC. | $33.11 | 2021 | |
| Coloplast Corp | $24.62 | 2024 | |
| Janssen Scientific Affairs, LLC | $21.87 | 2021 | |
| Mission Pharmacal Company | $21.37 | 2023 | Uribel |
| Vertex Pharmaceuticals Incorporated | $20.24 | 2025 | |
| Accord Healthcare, INC. | $14.97 | 2023 | |
| Halozyme INC | $14.67 | 2023 | |
| Acerus Pharmaceuticals Corporation | $14.59 | 2022 | |
| Convatec INC. | $14.39 | 2021 | |
| Rochester Medical Corporation | $13.36 | 2021 | |
| Zyla Life Sciences, INC. | $13.22 | 2019 | |
| Foundation Medicine, INC. | $12.65 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Cleary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.